A Study of Etavopivat for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS)

Clinical trial NCT05568225 · TERMINATED

Trial details

NCT number: NCT05568225
Sponsor: Forma Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R

Start date: 2022-11-15
Primary completion: 2024-07-15
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.